• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人卵巢癌中B7-H4、调节性T细胞与患者预后的关系

Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma.

作者信息

Kryczek Ilona, Wei Shuang, Zhu Gefeng, Myers Leann, Mottram Peter, Cheng Pui, Chen Lieping, Coukos George, Zou Weiping

机构信息

Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA.

出版信息

Cancer Res. 2007 Sep 15;67(18):8900-5. doi: 10.1158/0008-5472.CAN-07-1866.

DOI:10.1158/0008-5472.CAN-07-1866
PMID:17875732
Abstract

B7-H4 is a recently identified B7 family member. We previously showed that ovarian tumor and associated macrophages expressed B7-H4; tumor B7-H4+ macrophages and CD4+CD25+FOXP3+ regulatory T cells (Treg cells) suppressed tumor-associated antigen-specific T-cell immunity. To determine the pathologic relationship between B7-H4, macrophages, and Treg cells in the tumor environment, in addition to Treg cell numbers, we quantified B7-H4 expression in the tumor and tumor-associated macrophages in 103 patients with ovarian carcinoma. We observed that the intensity of B7-H4 expression in macrophages was significantly correlated with Treg cell numbers in the tumor. Further, both Treg cells and macrophage B7-H4, but not tumor B7-H4, were negatively associated with patient outcome. Tumor Treg cells enabled macrophages to spontaneously produce interleukin (IL)-10 and IL-6. Tumor macrophages stimulated B7-H4 expression in an autocrine manner through IL-10 and IL-6. Our previous work showed that tumor-associated macrophages spontaneously produced chemokine CCL22 to mediate Treg cell trafficking into tumor, and Treg cells induced B7-H4 on antigen-presenting cells (APC) including macrophages. Altogether, our data support the concept that there is a mechanistic interaction between Treg cells and macrophage, and that Treg cells may convey the suppressive activity to APCs through B7-H4 induction in human ovarian cancer.

摘要

B7-H4是最近发现的一种B7家族成员。我们之前的研究表明,卵巢肿瘤及相关巨噬细胞表达B7-H4;肿瘤中B7-H4阳性巨噬细胞和CD4+CD25+FOXP3+调节性T细胞(Treg细胞)可抑制肿瘤相关抗原特异性T细胞免疫。为了确定肿瘤环境中B7-H4、巨噬细胞和Treg细胞之间的病理关系,除了Treg细胞数量外,我们还对103例卵巢癌患者肿瘤及肿瘤相关巨噬细胞中的B7-H4表达进行了定量分析。我们观察到,巨噬细胞中B7-H4的表达强度与肿瘤中Treg细胞数量显著相关。此外,Treg细胞和巨噬细胞B7-H4,而非肿瘤B7-H4,均与患者预后呈负相关。肿瘤Treg细胞可使巨噬细胞自发产生白细胞介素(IL)-10和IL-6。肿瘤巨噬细胞通过IL-10和IL-6以自分泌方式刺激B7-H4表达。我们之前的研究表明,肿瘤相关巨噬细胞自发产生趋化因子CCL22以介导Treg细胞向肿瘤的迁移,且Treg细胞可在包括巨噬细胞在内的抗原呈递细胞(APC)上诱导B7-H4表达。总之,我们的数据支持以下观点:Treg细胞与巨噬细胞之间存在机制性相互作用,且在人类卵巢癌中Treg细胞可能通过诱导B7-H4将抑制活性传递给APC。

相似文献

1
Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma.人卵巢癌中B7-H4、调节性T细胞与患者预后的关系
Cancer Res. 2007 Sep 15;67(18):8900-5. doi: 10.1158/0008-5472.CAN-07-1866.
2
B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration.B7-H4(DD-O110)在高危子宫内膜样腺癌中过表达,且与肿瘤T细胞浸润呈负相关。
Gynecol Oncol. 2007 Jul;106(1):119-27. doi: 10.1016/j.ygyno.2007.03.039. Epub 2007 May 16.
3
Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma.白细胞介素-2的施用改变了卵巢癌患者的CD4+FOXP3+ T细胞库及肿瘤迁移情况。
Cancer Res. 2007 Aug 1;67(15):7487-94. doi: 10.1158/0008-5472.CAN-07-0565.
4
Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.白细胞介素2介导卵巢癌相关CD4+调节性T细胞转化为产生促炎白细胞介素17的辅助性T细胞。
J Immunother. 2009 Feb-Mar;32(2):101-8. doi: 10.1097/CJI.0b013e318195b59e.
5
Changes in the subpopulation of CD25+ CD4+ and FOXP3+ regulatory T cells in decidua with respect to the progression of labor at term and the lack of analogical changes in the subpopulation of suppressive B7-H4 macrophages--a preliminary report.足月分娩进展过程中蜕膜中CD25+ CD4+和FOXP3+调节性T细胞亚群的变化以及抑制性B7-H4巨噬细胞亚群缺乏类似变化——初步报告
Am J Reprod Immunol. 2009 Feb;61(2):136-46. doi: 10.1111/j.1600-0897.2008.00674.x.
6
Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells.前沿:通过白细胞介素-10在抗原呈递细胞上诱导B7-H4:调节性T细胞的新型抑制模式。
J Immunol. 2006 Jul 1;177(1):40-4. doi: 10.4049/jimmunol.177.1.40.
7
B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression.B7-H4在早期卵巢癌中过度表达,且与CA125表达无关。
Gynecol Oncol. 2007 Aug;106(2):334-41. doi: 10.1016/j.ygyno.2007.03.035. Epub 2007 May 11.
8
Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.在MRL/lpr小鼠中,CD4+、CD25+调节性T细胞的功能因抗原呈递细胞和效应T细胞的内在缺陷而受损。
Arthritis Rheum. 2008 Jun;58(6):1751-61. doi: 10.1002/art.23464.
9
Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway.通过激活B7-H4途径抑制人类T细胞对β细胞的反应。
Cell Transplant. 2006;15(5):399-410.
10
Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape.肿瘤相关巨噬细胞诱导肺癌细胞表面 B7-H4 的表达:免疫逃逸的一个潜在机制。
Cancer Lett. 2012 Apr 1;317(1):99-105. doi: 10.1016/j.canlet.2011.11.017. Epub 2011 Nov 20.

引用本文的文献

1
IL-10/STAT5 axis suppresses miR-140 to upregulate B7-H4 expression in RAW264.7 cells.白细胞介素-10/信号转导和转录激活因子5轴抑制微小RNA-140以上调RAW264.7细胞中B7-H4的表达。
Front Cell Infect Microbiol. 2025 Aug 15;15:1613297. doi: 10.3389/fcimb.2025.1613297. eCollection 2025.
2
Tertiary lymphoid structures: exploring opportunities to improve immunotherapy in ovarian cancer.三级淋巴结构:探索改善卵巢癌免疫治疗的机会
Front Immunol. 2025 May 22;16:1473969. doi: 10.3389/fimmu.2025.1473969. eCollection 2025.
3
Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements.
肿瘤微环境在卵巢癌转移及临床进展中的作用
J Transl Med. 2025 May 14;23(1):539. doi: 10.1186/s12967-025-06508-0.
4
Palmitoylation prevents B7-H4 lysosomal degradation sustaining tumor immune evasion.棕榈酰化可防止B7-H4被溶酶体降解,从而维持肿瘤免疫逃逸。
Nat Commun. 2025 May 8;16(1):4254. doi: 10.1038/s41467-025-58552-5.
5
Hyperinflammatory repolarisation of ovarian cancer patient macrophages by anti-tumour IgE antibody, MOv18, restricts an immunosuppressive macrophage:Treg cell interaction.抗肿瘤IgE抗体MOv18对卵巢癌患者巨噬细胞的超炎症性复极化限制了免疫抑制性巨噬细胞与调节性T细胞的相互作用。
Nat Commun. 2025 Apr 10;16(1):2903. doi: 10.1038/s41467-025-57870-y.
6
The role of B7-H4 in ovarian cancer immunotherapy: current status, challenges, and perspectives.B7-H4 在卵巢癌免疫治疗中的作用:现状、挑战和展望。
Front Immunol. 2024 Aug 29;15:1426050. doi: 10.3389/fimmu.2024.1426050. eCollection 2024.
7
The interactions of macrophages, lymphocytes, and mesenchymal stem cells during bone regeneration.骨再生过程中巨噬细胞、淋巴细胞和间充质干细胞之间的相互作用。
Bone Joint Res. 2024 Sep 6;13(9):462-473. doi: 10.1302/2046-3758.139.BJR-2024-0122.R1.
8
Tuning Immune-Cold Tumor by Suppressing USP10/B7-H4 Proteolytic Axis Reinvigorates Therapeutic Efficacy of ADCs.通过抑制 USP10/B7-H4 蛋白水解轴来调节免疫冷肿瘤,可重新激活 ADC 的治疗效果。
Adv Sci (Weinh). 2024 Oct;11(40):e2400757. doi: 10.1002/advs.202400757. Epub 2024 Aug 29.
9
B7H4 Role in Solid Cancers: A Review of the Literature.B7H4在实体癌中的作用:文献综述
Cancers (Basel). 2024 Jul 11;16(14):2519. doi: 10.3390/cancers16142519.
10
The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities.卵巢癌中的复杂肿瘤微环境:治疗挑战与机遇。
Curr Oncol. 2024 Jul 1;31(7):3826-3844. doi: 10.3390/curroncol31070283.